GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study
GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study have?
GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study has 123 citations in the OpenAlex counts ScholarIQ stores.
When was GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study published?
GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study has 2019 year in the ScholarIQ index.
What is the open-access status of GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study?
GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study has gold oa status in the ScholarIQ index.
What is the DOI of GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study?
The DOI for GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study is on the source record.
What is the PMID of GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study?
The PMID for GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study is on the source record.
What is the OpenAlex record for GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study?
The OpenAlex for GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study is on the source record.